Dennis Quaid's twins will get 250,000 dollars each from Los Angeles' Cedars-Sinai Medical Center, as part of a settlement related to the babies' near-fatal blood thinner overdose controversy.
Bosses at the centre have agreed to pay the amount to little Thomas Boone and Zoe Grace, who had to fight for life just 12 days after they were born in 2007.
A Settlement of $750,000 Made to Dennis Quaid Following Medication Overdose
The case of Medication overdose of the newborn twins of Hollywood actor Dennis Quaid and wife has been finally settled for 750,000 dollars with the Los Angeles hospital which was responsible for the error.
The case of Medication overdose of the newborn twins of Hollywood actor Dennis Quaid and wife has been finally settled for 750,000 dollars with the Los Angeles hospital which was responsible for the error.
The dispute between Quaid and his wife Kimberley Buffington and the hospital was settled last December, but lawyers for the couple insisted that that wasn't enough.
They said at the time that the babies had not recovered "completely from the effects of the injuries."
Nurses to Undergo Extra Training After Quaid Twins’ Accidental Overdose
1,400 nurses at L.A.’s Cedars-Sinai Medical Center are being forced to undergo extra training.
1,400 nurses at L.A.’s Cedars-Sinai Medical Center are being forced to undergo extra training.
Hospital officials have also agreed to provide future medical care for the babies if it is related to any mishap on their part.
Advertisement
US Halts Heparin Blood-thinner Imports
US authorities decided to put a stop to all imported blood-thinners and alerted the manufacturers to test them for contaminants.
US authorities decided to put a stop to all imported blood-thinners and alerted the manufacturers to test them for contaminants.
Quaid and his wife have launched a campaign for better bottle-labelling systems to prevent hospital tragedies across America.
Advertisement
Testicular Cancer Drug Trials Halted in UK Hospital After a Patient Dies of Overdose
Trials of a new testicular cancer drug, called TE 23, have been halted in one hospital in Britain after a 27-year-old patient died of overdose.
Trials of a new testicular cancer drug, called TE 23, have been halted in one hospital in Britain after a 27-year-old patient died of overdose.
LIN
